Didier TronoAfter obtaining an M.D. from the University of Geneva and completing a clinical training in pathology, internal medicine and infectious diseases in Geneva and at Massachusetts General Hospital in Boston, Didier Trono embarked in a scientific career at the Whitehead Institute for Biomedical Research of MIT. In 1990, he joined the faculty of the Salk Institute for Biological Studies to launch a center for AIDS research. He moved back to Europe seven years later, before taking the reins of the newly created EPFL School of Life Sciences, which he directed from 2004 to 2012. He is now actively engaged in the efforts of Switzerland to integrate new technologies in the fields of precision medicine and personalized health.
Cristina Ramona Cudalbu MoldovanCristina Cudalbu obtained her Bachelors of Science degree in Medical Physics in 2002 and Masters of Science degree in Biophysics and Medical Physics in 2003, both from University Babes-Bolyai, Cluj-Napoca, Romania. In 2006 she obtained her PhD degree in Localized Proton MRS and time domain quantification of cerebral metabolites at 7T and 4.7T at University Lyon 1, RMN Laboratory, Villeurbanne, France.In 2007, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented new acquisition and quantification techniques for in vivo nitrogen, proton and carbon MRS for preclinical studies. Starting 2012, Cristina Cudalbu was appointed as Research Staff Scientist and 9.4T MRI Operational Manager at Centre d’Imagerie Biomédicale (CIBM) at EPFL. She is now developing new research lines at CIBM, being oriented towards new acquisition and quantification techniques for in vivo proton, phosphorous, carbon, nitrogen MRS and fast MRSI, diffusion weighted spectroscopy and brain macromolecules quantification. She is now applying these developments on chronic hepatic encephalopathy, a research area that she developed at CIBM (https://actu.epfl.ch/news/when-liver-disease-affects-the-brain/), and on different collaborative projects with researchers from the five partner institutions of CIBM. Nikolaos StergiopoulosEducation
MTE, Managing the Technology Enterprise Program (2000), IMD, Lausanne
Ph.D. in Biomedical Engineering & Engineering Mechanics (1990) Iowa State University, Ames, Iowa.
MS in Biomedical Engineering (1987) Iowa State University, Ames, Iowa.
Diploma in Mechanical Engineering (1985) National Technical University of Athens.
Professional Activities
2002 - present: Professor and director of LHTC
2010 - present: Founder and director of Rheon Medical SA, Préverenges, Switzerland
2008 - present: Founder and director of Antlia S.A., PSE-C, EPFL campus, Switzerland
1998 - 2007: Founder and Scientific Director of EndoArt S.A., Lausanne, Switzerland
1996 - 2002: Assistant professor at the Biomedical Engineering Laboratory, Swiss Federal Institute of Technology, Lausanne, Switzerland.
1991 - 1996: Research Associate at Swiss Federal Institute of Technology - Lausanne
1990 - 1991: Lecturer, Iowa State University
Farhad Rachidi-HaeriFarhad Rachidi (IEEE Fellow, EMP Fellow, Electromagnetics Academy Fellow) was born in Geneva in 1962. He received the M.S. degree in electrical engineering and the Ph.D. degree from the Swiss Federal Institute of Technology, Lausanne, in 1986 and 1991 respectively.
He worked at the Power Systems Laboratory of the same institute until 1996 and had several short stays at the University of Florida and the NASA Kennedy Space Center. In 1997, he joined the Lightning Research Laboratory of the University of Toronto in Canada and from April 1998 until September 1999, he was with Montena EMC in Switzerland. He is currently a titular professor and the head of the EMC Laboratory at the Swiss Federal Institute of Technology, Lausanne, Switzerland.
His research interests concern electromagnetic compatibility, lightning electromagnetics and electromagnetic field interactions with transmission lines.
Dr. Rachidi is currently a member of the Advisory Board of the IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY and the President of the Swiss National Committee of the International Union of Radio Science.
He has received numerous awards including the 2005 IEEE EMC Technical Achievement Award, the 2005 CIGRE Technical Committee Award, the 2006 Blondel Medal from the French Association of Electrical Engineering, Electronics, Information Technology and Communication (SEE), the 2016 Berger Award from the International Conference on Lightning Protection, the 2016 Best Paper Award of the IEEE Transactions on EMC, and the 2017 Motohisa Kanda Award for the most cited paper of the IEEE Transactions on EMC (2012-2016).
In 2014, he was conferred the title of Honorary Professor of the Xi’an Jiaotong University in China.
He served as the Vice-Chair of the European COST Action on the Physics of Lightning Flash and its Effects from 2005 to 2009, the Chairman of the 2008 European Electromagnetics International Symposium, the President of the International Conference on Lightning Protection from 2008 to 2014, the Editor-in-Chief of the Open Atmospheric Science Journal (2010-2012) and the Editor-in-Chief of the IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY from 2013 to 2015. He is a Fellow of the IEEE and of the SUMMA Foundation, and a member of the Swiss Academy of Sciences.
He is the author or coauthor of over 200 scientific papers published in peer-reviewed journals and over 400 papers presented at international conferences.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
Benjamin Marcel Daniel RothéInterests - Ribonucleoparticles biogenesis- Regulation of mRNA translation- Protein phase separation Education PhD | Biochemistry and Molecular Biology 2007 – 2012 University of Lorraine - Nancy I - FRANCE
Horst PickTeaching & PhD PhD Students Vivek Prakash, Yang Wang Past EPFL PhD Students as codirector Olivia Baud, Thamani Dahoun, Enio Daniel Zanchetta Courses Biotechnology lab (for CGC) ChE-433 This laboratory-training course is designed to give students a comprehensive insight into laboratory research techniques in the field of biotechnology and pharmaceutical biotechnology with practices employed in the industry. Accompanying lectures provide the theoretical background. Chemosensory receptors:
